Antibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations
- Western blot [3]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN267487 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Heterogeneous Nuclear Ribonucleoprotein L (HNRNPL) antibody
- Antibody type
- Monoclonal
- Description
- Protein G purified
- Reactivity
- Human, Mouse, Rat, Bovine, Chicken/Avian, Simian
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- 4D11
- Vial size
- 0.1 mL
- Storage
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
- Handling
- Avoid freeze-thaw cycles
Submitted references Interplay between miR-574-3p and hnRNP L regulates VEGFA mRNA translation and tumorigenesis.
Immunoprecipitation and mass spectrometry defines an extensive RBM45 protein-protein interaction network.
The HILDA complex coordinates a conditional switch in the 3'-untranslated region of the VEGFA mRNA.
Diverse roles of hnRNP L in mammalian mRNA processing: a combined microarray and RNAi analysis.
HnRNP L stimulates splicing of the eNOS gene by binding to variable-length CA repeats.
Inflammation modulates the interaction of heterogeneous nuclear ribonucleoprotein (hnRNP) I/polypyrimidine tract binding protein and hnRNP L with the 3'untranslated region of the murine inducible nitric-oxide synthase mRNA.
Regulation of human vascular endothelial growth factor mRNA stability in hypoxia by heterogeneous nuclear ribonucleoprotein L.
Heterogeneous nuclear ribonucleoprotein L interacts with the 3' border of the internal ribosomal entry site of hepatitis C virus.
HnRNP L binds a cis-acting RNA sequence element that enables intron-dependent gene expression.
Yao P, Wu J, Lindner D, Fox PL
Nucleic acids research 2017 Jul 27;45(13):7950-7964
Nucleic acids research 2017 Jul 27;45(13):7950-7964
Immunoprecipitation and mass spectrometry defines an extensive RBM45 protein-protein interaction network.
Li Y, Collins M, An J, Geiser R, Tegeler T, Tsantilas K, Garcia K, Pirrotte P, Bowser R
Brain research 2016 Sep 15;1647:79-93
Brain research 2016 Sep 15;1647:79-93
The HILDA complex coordinates a conditional switch in the 3'-untranslated region of the VEGFA mRNA.
Yao P, Potdar AA, Ray PS, Eswarappa SM, Flagg AC, Willard B, Fox PL
PLoS biology 2013;11(8):e1001635
PLoS biology 2013;11(8):e1001635
Diverse roles of hnRNP L in mammalian mRNA processing: a combined microarray and RNAi analysis.
Hung LH, Heiner M, Hui J, Schreiner S, Benes V, Bindereif A
RNA (New York, N.Y.) 2008 Feb;14(2):284-96
RNA (New York, N.Y.) 2008 Feb;14(2):284-96
HnRNP L stimulates splicing of the eNOS gene by binding to variable-length CA repeats.
Hui J, Stangl K, Lane WS, Bindereif A
Nature structural biology 2003 Jan;10(1):33-7
Nature structural biology 2003 Jan;10(1):33-7
Inflammation modulates the interaction of heterogeneous nuclear ribonucleoprotein (hnRNP) I/polypyrimidine tract binding protein and hnRNP L with the 3'untranslated region of the murine inducible nitric-oxide synthase mRNA.
Söderberg M, Raffalli-Mathieu F, Lang MA
Molecular pharmacology 2002 Aug;62(2):423-31
Molecular pharmacology 2002 Aug;62(2):423-31
Regulation of human vascular endothelial growth factor mRNA stability in hypoxia by heterogeneous nuclear ribonucleoprotein L.
Shih SC, Claffey KP
The Journal of biological chemistry 1999 Jan 15;274(3):1359-65
The Journal of biological chemistry 1999 Jan 15;274(3):1359-65
Heterogeneous nuclear ribonucleoprotein L interacts with the 3' border of the internal ribosomal entry site of hepatitis C virus.
Hahm B, Kim YK, Kim JH, Kim TY, Jang SK
Journal of virology 1998 Nov;72(11):8782-8
Journal of virology 1998 Nov;72(11):8782-8
HnRNP L binds a cis-acting RNA sequence element that enables intron-dependent gene expression.
Liu X, Mertz JE
Genes & development 1995 Jul 15;9(14):1766-80
Genes & development 1995 Jul 15;9(14):1766-80
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC